why choose us

First received: November 29, 2022

Clinical Trial: A Study to Evaluate Efficacy and Safety of VX-864 in Participants With the PiZZ Genotype

Study Status: ACTIVE_NOT_RECRUITING

Recruit Status: ACTIVE_NOT_RECRUITING

Condition: Alpha-1 Antitrypsin Deficiency

Study Type: INTERVENTIONAL


Official Title: A Phase 2, Open-label Study Evaluating Efficacy and Safety of VX-864 in Subjects With Alpha-1 Antitrypsin Deficiency Who Have the PiZZ Genotype, Over 48 Weeks

Brief Summary: The purpose of this study is to evaluate the efficacy and safety of VX-864 in participants with the PiZZ genotype over 48 weeks.

Read more